SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000904454-20-000018
Filing Date
2020-01-09
Accepted
2020-01-09 17:18:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G FOR MILESTONE PHARMACEUTICALS INC. BY DOMAIN PARTNERS VIII, L.P. s13g_010920-milestonepharm.htm SC 13G 29552
  Complete submission text file 0000904454-20-000018.txt   31136
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Subject) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91001 | Film No.: 20518812
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE, SUITE 515 PRINCETON NJ 08542
Business Address C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE, SUITE 515 PRINCETON NJ 08542 609-683-5656
Domain Partners VIII, L.P. (Filed by) CIK: 0001465144 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G